Linton, K, Davies, A, Gopal, AK, Kahl, BS, Vos, SD, Wagner-Johnston, ND, Schuster, SJ, Jurczak, WJ, Flinn, IW, Flowers, CR, Martin, P, Viardot, A, Blum, KA, Goy, AH, Gribben, U, Arkenau, H-T, Johnson, R, Zinzani, PL, Dreyling, M, Renner, C, Holes, L, Li, D, Dansey, RD, Godfrey, WR & Salles, GA 2014, '
Mature Response Data from A Phase 2 study of PI3K-Delta Inhibitor Idelalisib in patients with Double (Rituximab and Alkylating agent)-Refractory indolent B-cell Non-Hodgkin Lymphoma (iNHL)', British Haematology Society Annual Meeting, Birmingham, UK,
1/01/24.